Biotech China 2014
Antibodies Europe: Engineering the Next Generation of Antibodies Nov (07-08)
InterContinental Wien
1037 Vienna, Austria
Vienna,
http://www.healthtech.com/2007/rbe/day1.asp
Keywords: Antibodies Europe, Cambridge Healthtech Institute, InterContinental Wien

Schedule of Presentations:

Wednesday, November 7, 2007
08:00:00 Registration and Morning Coffee (08:00-09:00)
09:00:00 Welcome by Session Chairperson (09:00-09:15) Lutz Jermutus
09:15:00 Protecting Antibody IP Across Continents: Protecting Antibodies via Intellectual Property for the US Market (09:15-10:00) Sarah A. Kagan
10:00:00 Engineering Therapeutics (10:00-11:30) Robert Kelley, Anne S. De Groot
10:00:00 Engineering Therapeutics: Fc Engineering of Therapeutic Antibodies (10:00-10:30) Robert Kelley
10:30:00 Engineering Therapeutics: New Approaches to Immunogenicity: Screening, Reengineering and Modulation (10:30-11:00) Anne S. De Groot
11:00:00 Engineering Therapeutics: Poster and Exhibit Viewing, Coffee Break (11:00-11:30)
11:30:00 Improving Selection and Libraries: De Novo Identification of Binding Sequences for Antibody Replacement Molecules (11:30-12:00) Stephen Quirk
11:30:00 Improving Selection and Libraries (11:30-14:10) Stephen Quirk, Philippe Mondon, Julio A. Camarero
12:00:00 Improving Selection and Libraries: Method for Generation of Human Hyperdiversified Antibody Fragment Libraries (12:00-12:30) Philippe Mondon
12:30:00 Improving Selection and Libraries: A Cell-Based Approach for the Biosynthesis/Screening of Cyclotide-Based Libraries against Bacterial Toxins (12:30-13:00) Julio A. Camarero
13:00:00 Improving Selection and Libraries: Lunch on Your Own (13:00-14:10)
14:10:00 Solving Antibody Problems (14:10-16:15) Ozlem Tureci, John Gasdaska, Steffen Goletz, Herta Steinkellner
14:10:00 Solving Antibody Problems: Comments by Session Chairperson (14:10-14:15) Steffen Goletz
14:15:00 Solving Antibody Problems: Glyco-Optimized Rituximab Produced Has Enhanced ADCC Activity (14:15-14:45) John Gasdaska
14:45:00 Solving Antibody Problems: Generation of Glycan Optimized IgGs in Glycoengineered Plants (14:45-15:15) Herta Steinkellner
15:15:00 Solving Antibody Problems:Development of New Antibody Therapeutics for Solid Cancers Based on Ideal Targets (15:15-15:45) Ozlem Tureci
15:45:00 Solving Antibody Problems: Poster and Exhibit Viewing, Refreshment Break (15:45-16:15)
16:15:00 Engineering for Optimum Performance and Yield: Advanced Technology for the Next Generation of Monoclonal Antibodies (16:15-16:45) Masahiro Tomita
16:15:00 Engineering for Optimum Performance and Yield (16:15-19:15) Ekkehard Mössner, Frank Carr, Ping Zhong, Masahiro Tomita
16:45:00 Engineering for Optimum Performance and Yield: Next Generation Antibodies with Enhanced Effector Functions (16:45-17:15) Ekkehard Mössner
17:15:00 Engineering for Optimum Performance and Yield: Overcoming Adverse Immunogenicity against Therapeutic Proteins for the Treatment of Cancer (17:15-17:45) Frank Carr
17:45:00 Engineering for Optimum Performance and Yield: Antibody Optimization by AISIM Technology (17:45-18:15) Ping Zhong
18:15:00 Engineering for Optimum Performance and Yield: Networking Reception in Exhibit Hall (18:15-19:15)
19:15:00 Close of Conference Day
Thursday, November 8, 2007
08:30:00 Morning Coffee (08:30-08:55)
08:55:00 Emerging Technologies; The Next Generation (08:55-12:00) Paul Watt, Joost A Kolkman, Kaspar Binz, Andreas Hohlbaum, Thomas Huber, Anthony Keefe
08:55:00 Emerging Technologies; The Next Generation: Comments by Session Chairperson (08:55-09:00) Joost A Kolkman
09:00:00 Emerging Technologies; The Next Generation: Phylomers: Synthetic Peptides Derived from Protein Fragments Suitable for Intracellular as Well as Extracellular Targets (09:00-09:30) Paul Watt
09:30:00 Emerging Technologies; The Next Generation: Moving Beyond Antibodies: Anticalins®, A Novel Class of Therapeutic Proteins (09:30-10:00) Andreas Hohlbaum
10:00:00 Emerging Technologies; The Next Generation: In Vitro Selection and Characterization of DARPins and Fab Fragments for the Co-Crystallization of Membrane Proteins (10:00-10:30) Thomas Huber
10:30:00 Emerging Technologies; The Next Generation: Poster and Exhibit Viewing, Coffee Break (10:30-11:00)
11:00:00 Emerging Technologies; The Next Generation: DARPins for Targeted Tumor Therapy and Diagnosis (11:00-11:30) Kaspar Binz
11:30:00 Emerging Technologies; The Next Generation: Aptamers - An Antibody Alternative (11:30-12:00) Anthony Keefe
12:00:00 Emerging Technology Focus: Computer Aided Multi-Parameter Gene Design: Impact of Synthetic DNAs on Antibody Expression in CHO Cell Lines (12:00-12:15) Marcus Graf
12:15:00 Emerging Technology Focus: TBA (12:15-12:30)
12:30:00 Emerging Technology Focus: Lunch on Your Own (12:30-13:40)
13:40:00 Applications and Case Studies (13:40-16:45) Joost A Kolkman, Laetitia Devy, Tobias Raum, Stefan Dübel, Ann Depicker, Jianbing Zhang
13:40:00 Applications and Case Studies: Comments by Session Chairperson (13:40-13:45) Joost A Kolkman
13:45:00 Applications and Case Studies: Tumor Targeting with Chimeric Heavy Chain Antibodies (13:45-14:15) Jianbing Zhang
14:15:00 Applications and Case Studies: Single Chain Fab (scFab) Fragment and Human Targeted RNases (14:15-14:45) Stefan Dübel
14:45:00 Applications and Case Studies: Plant Seeds as Bioreactor for the Production of scFv-Fc Antibody Variants (14:45-15:15) Ann Depicker
15:15:00 Applications and Case Studies: Poster and Exhibit Viewing, Refreshment Break (15:15-15:45)
15:45:00 Applications and Case Studies: Antibodies as Protease Inhibitors (15:45-16:15) Laetitia Devy
16:15:00 Applications and Case Studies: Adecatumumab: A Human Antibody for Tumor Therapy (16:15-16:45) Tobias Raum
16:45:00 Close of Antibodies – Europe Conference
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.